Clearside Biomedical Financials Show Significant Capital Underperformance
Clearside Biomedical, Inc. (NASDAQ:CLSD) reported a return on invested capital (ROIC) of -177.13%. This is significantly below its weighted average cost of capital (WACC) of 17.35%. The company is not generating positive returns on invested capital.
The company's ROIC to WACC ratio stands at -10.21. This metric highlights inefficiencies in Clearside's capital utilization.
In comparison, Cidara Therapeutics reported a ROIC of -46.99% and a WACC of 10.99%. Its ROIC to WACC ratio was -4.27.
Selecta Biosciences reported a positive ROIC of 6.80% and a WACC of 8.38%. This yielded a ROIC to WACC ratio of 0.81.
vTv Therapeutics and Corvus Pharmaceuticals also posted negative ROIC to WACC ratios of -19.61 and -7.99, respectively.
Clearside Biomedical is a biopharmaceutical firm developing therapies for eye diseases. Investors can find more information on the company's history and mission at Clearside Biomedical history, mission, and ownership. Further details on its vision are available at Clearside Biomedical mission and vision. The company's financial health is discussed at Clearside Biomedical financial health, and an investor profile can be viewed at Clearside Biomedical investor profile.
Clearside Biomedical, Inc. (CLSD) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.